Status:
COMPLETED
Intervention Targeting Motivational Negative Symptoms
Lead Sponsor:
University of Liege
Collaborating Sponsors:
Fonds National de la Recherche Scientifique
Conditions:
Schizophrenia
Schizo Affective Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to investigate the effects of the Switch intervention on motivation and associated processes and explore the dynamics between the processes. A single case approach is followed, with a...
Detailed Description
Motivational negative symptoms hinder quality of life and daily functioning of individuals with schizophrenia spectrum, bipolar and major depressive disorders. A recently developed intervention, Swit...
Eligibility Criteria
Inclusion
- Diagnostic and Statistical Manual-V (DSM-V) criteria for schizophrenia, schizoaffective, bipolar or major depressive disorder (American Psychiatric Association, 2013).
- Good understanding of French.
Exclusion
- Presenting an unstable clinical picture;
- Evidence of a significant change in medication within one month prior to baseline assessment;
- Having a history of severe brain trauma or epilepsy;
- Comorbid intellectual disability;
- Moderate or severe substance use disorder other than tobacco (according to the DSM-V; i.e., showing 4 or more symptoms).
Key Trial Info
Start Date :
April 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04325100
Start Date
April 20 2019
End Date
February 27 2020
Last Update
March 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Liege
Liège, Belgium, 4000